Skip to main content

ORBIMED ADVISORS LLC

Position in TMO — Thermo Fisher Scientific Inc.

CIK 1055951 New York, NY

Position in TMO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$22,856,145
-$4,088,280 QoQ
Shares Held
46,500
0.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.46%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Common Shares in TMO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

ORBIMED ADVISORS LLC holds $728,348,629 across 5 Diagnostics & Research names. TMO ranks #5 (3.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 TMO
Thermo Fisher Scientific Inc.
This page
46,500 $22,856,145

All Filings in TMO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $22,856,145 46,500
2025-12-31 $26,944,425 46,500
2025-09-30 $22,553,430 46,500
2025-06-30 $18,853,890 46,500
2025-03-31 $64,190,400 129,000
2024-12-31 $43,907,412 84,400
2024-09-30 $52,207,308 84,400
2024-06-30 $72,996,000 132,000
2024-03-31 $76,719,720 132,000
2023-12-31 $76,327,602 143,800
2023-09-30 $72,787,246 143,800
2023-06-30 $84,940,900 162,800
2023-03-31 $85,187,486 147,800
2022-12-31 $111,349,518 202,200
2022-09-30 $102,553,818 202,200
2022-06-30 $61,607,952 113,400
2022-03-31 $71,232,390 120,600
2021-12-31 $63,187,628 94,700
2021-09-30 $63,017,699 110,300
2021-06-30 $55,643,041 110,300
2021-03-31 $50,338,714 110,300
2020-12-31 $51,375,534 110,300
2020-09-30 $48,699,656 110,300
2020-06-30 $39,966,102 110,300
2020-03-31 $31,281,080 110,300